 AIM ImmunoTech Inc NYSE:AIM announced that it has entered into a lease agreement with the New Jersey Economic Development Authority for a 5,210 square foot research and development RD facility at the state-supported New Jersey Bioscience Center NJBC. The immuno-pharma company said the incubator at North Brunswick, New Jersey, which is designed for small businesses in the region, is dedicated to life sciences and biotechnology companies, and the NJBC has invested over 70 million in facilities and improvements to its campus. 